COMMUNIQUÉS West-GlobeNewswire

vTv Therapeutics Announces USPTO Allowance of Patent Covering Cadisegliatin
11/08/2025
HIGH POINT, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin , a potential first-in-class oral adjunctive [...]
Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results
11/08/2025
- Released positive topline data from the VIRAGE Phase 2b study of VCN-01 (zabilugene almadenorepvec); expanded data to be presented at the European Society for Medical Oncology (ESMO) 2025 Congress in October - - VCN- [...]
Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025
11/08/2025
COPENHAGEN, Denmark, August 11, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its [...]
Full Alliance Group’s Qubitera Holdings Expands Quant Blockchain Healthcare Development Roadmap
11/08/2025
Qubitera Holdings Charts Mid-2027 Global Launch for Quantum-Safe EHR/EMR Platform TAMPA, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) announced today that its subsidiary, Qubitera [...]
Safety Shot Announces Strategic Alliance with Bonk Founding Contributors, Initiating BONK Treasury Strategy
11/08/2025
Company to Receive $25 Million in BONK Tokens from Founding Contributors of BONK, Establishing a New Model for Public Company Participation in DeFi SCOTTSDALE, AZ, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. ( [...]
Veru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study
11/08/2025
MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory [...]
Oragenics Q2 2025 Shareholder Update
11/08/2025
Advancing Brain-First Recovery Platform Toward Clinical Milestones Pioneering Intranasal Therapeutics for Concussion SARASOTA, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering [...]
XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics
11/08/2025
- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right - EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a [...]
FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy
11/08/2025
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025
11/08/2025
Presentation will be the interim data from the Phase 2 study of istaroxime in SEISMiC C - Cardiogenic Shock SCAI Stage C Cardiogenic shock SCAI Stage C has an in hospital mortality rate of 20-30% Istaroxime interim data [...]
Artelo Biosciences Receives Notice of Allowance from European Patent Office for the Patent Claims for the Intended Commercial Formulation of ART27.13
11/08/2025
Extends Patent Protection Through December 2041 ART27.13 is Currently under Evaluation in a Phase 2 Study for the Treatment of Cancer-Related Anorexia SOLANA BEACH, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Artelo [...]
BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results
11/08/2025
SUNNYVALE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported [...]
PharmaTher Announces FDA Approval of Ketamine (KETARx™)
11/08/2025
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of [...]
REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
11/08/2025
WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a [...]
TOMI Environmental Solutions Secures Order from ARES Distribution
11/08/2025
FREDERICK, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced that it has [...]
Managed Healthcare Executive® announces 2025 PBMI Innovators Award winners
11/08/2025
Celebrating six visionaries driving meaningful innovation in pharmacy benefit management CRANBURY, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Managed Healthcare Executive® is proud to announce the winners of the 2025 PBMI [...]
Rising Cyber Threats to Brazil’s Health Sector Highlighted in New Health-ISAC Report
11/08/2025
Attacks on Brazil’s health system are rising, and limited intelligence sharing is contributing to put patient data and critical infrastructure at risk. ORLANDO, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Health-ISAC, a non [...]
Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
11/08/2025
Tinlarebant granted Breakthrough Therapy Designation for Stargardt disease (STGD1) by the U.S. Food and Drug Administration (FDA) DRAGON trial completion expected by Q4 2025 (including a three-month follow-up period) [...]
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry
11/08/2025
VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the [...]

Pages